Clinical Trial Update: Short-course Regimens for the Treatment of Pulmonary Tuberculosis [Phase 2, Phase 3]

View source ↗

Summary

ClinicalTrials.gov update on Phase 2 and Phase 3 trials evaluating short-course regimens for pulmonary tuberculosis and latent tuberculosis infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Latent Tuberculosis Infection
• Pulmonary Tuberculosis

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Tuberculosis, Pulmonary, Tuberculosis Infection | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING